METHODS OF DETERMINING A TREATMENT PROTOCOL FOR AND/OR A PROGNOSIS OF A PATIENT'S RECOVERY FROM A BRAIN INJURY
First Claim
Patent Images
1. A method for determining a measure of the concentration of tau protein in a patient sample containing or suspected of containing tau protein, comprising:
- performing an assay to determine a measure of the concentration of tau protein in the sample, wherein the limit of detection of tau protein of the assay is less than about 0.2 pg/mL.
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention, in some embodiments, generally relates to methods of determining a treatment protocol for and/or a prognosis of a patient'"'"'s recovery from a brain injury. In some embodiments, the brain injury results from a hypoxic event. In some embodiments, methods are provided for determining a measure of the concentration of tau protein in a patient sample containing or suspected of containing tau protein.
-
Citations
25 Claims
-
1. A method for determining a measure of the concentration of tau protein in a patient sample containing or suspected of containing tau protein, comprising:
performing an assay to determine a measure of the concentration of tau protein in the sample, wherein the limit of detection of tau protein of the assay is less than about 0.2 pg/mL. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11)
-
12. A method of determining a treatment protocol for and/or a prognosis of a patient'"'"'s recovery from a brain injury comprising:
-
performing an assay on a blood sample from the patient and/or plasma and/or serum derived from the blood sample to determine a measure of the concentration of tau protein in the sample; and determining a prognosis of the patient'"'"'s recovery from the brain injury and/or a method of treatment based at least in part on the measured concentration of tau protein present in the sample. - View Dependent Claims (13, 20, 21, 22, 23, 24)
-
-
14. A method of determining a treatment protocol for and/or a prognosis of a patient'"'"'s recovery from a brain injury, comprising:
determining a prognosis of the patient'"'"'s recovery from the brain injury and/or a method of treatment based at least in part on a measured concentration of tau protein present in a patient sample, wherein the measured concentration has been determined by performing an assay on the patient sample, which comprises a blood sample from the patient and/or plasma and/or serum derived from the blood sample, to determine the measure of the concentration of tau protein in the sample. - View Dependent Claims (15)
-
16-19. -19. (canceled)
-
25-91. -91. (canceled)
Specification